How we create value
In a rapidly changing business environment, our strategy and business model help us deliver on our purpose and create value for our company and society.
Our business environment
Our strategic priorities
Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science.
Unleash the power of our people We are transforming our culture to ensure people can fully apply their talent and energy. We’re creating an organization where people are inspired, curious and unbossed. Deliver transformative innovation In our pursuit of transformative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life. Embrace operational excellence We are rethinking how we work, embracing agile teams and building better productivity into our company to free resources that we can invest in innovation and help boost returns. Go big on data and digital We aim to spark a digital revolution at Novartis, embracing digital technologies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency. Build trust with society We strive to build trust with society through finding new ways to expand patients’ access to our treatments and operating with integrity.
Our business model
Resources we use
We depend on the skills and creativity of our employees to discover, develop and produce new medicines, and deliver them to patients.
We use cash, equity and debt to meet our financial commitments, make investments and pay dividends.
We use expertise and data to develop and market our products. We hold patents and trademarks that protect the long-term investments required for our business.
We responsibly consume energy, water and other resources to manufacture our products and operate our business.
We own or lease research laboratories, manufacturing sites and offices around the world. We use artificial intelligence, gene editing and other technologies.
We build trusted relationships with stakeholders to bring treatments to patients, advance drug discovery and expand patient access.
The value we create
This infographic is informed by the framework of the International Integrated Reporting Council (IIRC).